Resources from the same session
Recurrence Post-Radical Resection: Are Systemic Therapies the Solution to Optimize Patient Outcomes?
Presenter: Andrea Necchi
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
Biomarkers: Are We Ready to Use Them in Routine Clinical Practice?
Presenter: Matthew Galsky
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
QoL: Is It a Key Endpoint in the Adjuvant Setting?
Presenter: Matthew Galsky
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
Clinical Cases Discussion (Cisplatin-eligible case; Cisplatin-ineligible case)
Presenter: Matthew Galsky
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
Live Q&A session
Presenter: James Catto
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast